NCT02260141终止不适用
Treating Alzheimer's and Dementia With D-ribose
Practitioners Alliance Network2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2014年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 3
- 试验地点
- 2
- 主要终点
- ADAS-ADL
研究概览
简要总结
To study the effectiveness of d-ribose in treating Alzheimer's and Dementia
详细描述
Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm 3 X day for 8 weeks to monitor outcomes in a pilot study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A diagnosis of Alzheimer's and/or dementia with a Mini Mental Status Exam ( MMSE) score over 12 or being ambulatory and able to travel outside the home with assistance.
- •Must have a caregiver living with them.
排除标准
- •Overt and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness.
- •Also, severe life threatening illnesses which would make them unlikely to be alive after 6-12 months.
结局指标
主要结局
ADAS-ADL
时间窗: 2 months
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal FluidAlzheimer's DiseaseNCT00439166Hamilton Health Sciences Corporation100
已完成
2 期
Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's DiseaseAlzheimer's DiseaseNCT02792257Johns Hopkins University84
已完成
2 期
Insulin, Neurogenetics and Memory in Alzheimer's DiseaseAlzheimer DiseaseNCT00018382US Department of Veterans Affairs
Enrolling By Invitation
不适用
Cholinergic Deep Brain Stimulation for Alzheimer's DiseaseAlzheimer Disease, Early OnsetDementiaAlzheimer DiseaseNCT05882344Vanderbilt University Medical Center2
已完成
不适用
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed DementiaDementiaAlzheimer's DiseaseNCT01023867Samsung Medical Center88